IDEAYA Biosciences, Inc. (IDYA) vs Tarsus Pharmaceuticals, Inc. (TARS)
IDEAYA Biosciences, Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. IDEAYA Biosciences, Inc. and Tarsus Pharmaceuticals, Inc. are of similar size ($3.6B and $3.6B). IDEAYA Biosciences, Inc. grew revenue faster over the last twelve months: 901.2% against 105.2%. Tarsus Pharmaceuticals, Inc. has the higher net margin (−7.67% vs −74.8%) and the higher return on invested capital (0.00% vs −36.7%). Across the 17 metrics below, Tarsus Pharmaceuticals, Inc. leads on 10 and IDEAYA Biosciences, Inc. on 7.
Valuation
Profitability
| Metric | IDYA | TARS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 93.28% | 65.16% |
| Operating margin | (92.66%) | (8.00%) | 0.00% |
| Net margin | (74.75%) | (7.67%) | 0.00% |
| Free cash flow margin | (48.64%) | 9.24% | 0.00% |
| Return on equity | (16.22%) | (13.68%) | (57.72%) |
| Return on assets | (14.89%) | (8.40%) | (49.22%) |
| Return on invested capital | (36.65%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack